CD63+tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelialmesenchymal transition and lipid reprogramming

Tumor-associated macrophages (TAMs) constitute a substantial part of human hepatocellular carcinoma (HCC). The present study was devised to explore TAM diversity and their roles in HCC progression.